As an owner (of the cameras) they would have to significantly improve battery life. market size etc important of course but better battery life trump all else.
Understand, I agree with everything you say which was why I bought the stock in size around 10 (some slightly about then more sub 10). A company with a market cap of pushing $250,000 before netting out cash with a product rollout that gave me pause, and a 40+% profitin a hyper voluital stock, out it went. Prudent management
Agree, how about Apple, or lisa. I was concerned the the "TM" trademark wasn't apparent. I see it now. I have seem many companies not do do diligence on trade marks and have much difficulty. A i Google "hotshot" I get bug killers and a bunch of other things, all trademarked. point 2 is using that name they better paid up to get their name at the top of the search list. Marketing screwup not to get that done in advance. Bottom lineis even if you want to buy the product now which is on line at a time when there is heavy sport activity==the summer, it should be easier to get, particularly by earily adopters, and opinion leaders as the stealth market approach is all about that and word of mouth. Momentum in this rollout is essential or it just looks like another herbal suppliment of which there are many that come up in searches.
Seems like I should have waited, but if I didn't know better I would think the company is buying stock back or at the least someone is walking the stock higher as the preponderance of the activity has been bids being hit.
Good news =rollout.Bad news= very hard to find the site to buy it. Also when you google Hotshot, you get a bunch of places to buy bug killers. Also the bug killer name is trademarked, I hope they locked in trademark for product. I sold my shares today as it seemed prudent given the volatility and what looks like a stumble in their "guerrilla marketing" approach. Good approach for product like this BUT you better do it right or you are toast. Will revisit as an objective, non-owner. Has served me well so far.
forgot to add the puzzle was the surge this morning in that a lot of calls were exercised Friday which including preminum paid on purchase were marginally profitable or loss. Many don't want to be long the stock but the writer must buy to deliver. So follow through may be challenging.
Should give up down to 93.20 or loss for the day.
Question is who gave your post a thumbs down? Like politics you get pilloried for stating facts. Laughable. Looks like good molecule with lots of promise, but biotech are under fire so trying to model profitability is daunting. Lots of moving parts, out of the industries control hence what appears to be low valuation for this and other companies in the field.